Name
Aktsiaselts MAGNUM
Registry code
12371718
VAT number
EE101106531
Type
AS - Joint Stock Company
Status
Registered
Foundation date
01.11.2012 (11)
Financial year
01.05-30.04
Capital
25 000.00 €
Activity
70221 - Business and other management consultancy activities 63111 - Data processing, hosting and related activities 77401 - Leasing of intellectual property and similar products, except copyrighted works 69202 - Bookkeeping, tax consulting
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| MM Pharma OÜ 14080511 | 100% - 25 000.00 EUR | - | - | Shareholder |
| Mari Krass 06.05.1977 (47) | - | Board member | - | |
| Marika Pensa 14.08.1973 (51) | - | Board member | - | |
| Veiko Vetto 13.06.1974 (50) | - | Board member | - | |
| Omanikukonto: MARGUS LINNAMÄE 05.01.1964 (60) | - | - | Indirect ownership | Chairman of the board |
| Ahti Kallikorm 03.01.1963 (61) | - | - | - | Board member |
| Anu Sofia Kuks 28.08.1966 (58) | - | - | - | Board member |
| Margus Kähri 31.12.1978 (45) | - | - | - | Board member |
| Kristel Volver 30.08.1990 (34) | - | - | - | Board member |
| MM Grupp OÜ 10515366 | - | - | - | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Magnum Dental OÜ 10351798 | 75% - 7 500.00 EUR | - | - | |
| Allium UPI OÜ 11331786 | 100% - 2 556.00 EUR | - | - | |
| MAGNUM LOGISTICS OÜ 11331792 | 100% - 2 556.00 EUR | - | - | |
| MAGNUM MEDICAL OÜ 11332521 | 100% - 2 556.00 EUR | - | - | |
| Apteegi Beauty OÜ 14416750 | 100% - 2 500.00 EUR | - | - | Founder |
| Allium Pharma OÜ 14192368 | 100% - 2 500.00 EUR | - | - | |
| TPA Narva Apteegid OÜ 14160210 | 100% - 2 500.00 EUR | - | - | |
| OÜ Narva-Jõesuu Apteek 11820456 | 49% - 2 454.00 EUR | - | - | |
| Aktsiaselts Magnum Veterinaaria 10007517 | 100% - 223 051.00 EUR | - | - | Shareholder |
| 2019 30.10.2020 | 2020 30.10.2021 | 2021 30.10.2022 | 2022 30.10.2023 | |
|---|---|---|---|---|
| Total Revenue | 5 754 856 € | 5 768 198 € | 6 585 102 € | 7 128 955 € |
| Net profit (loss) for the period | -70 300 € | -242 175 € | -137 303 € | 921 107 € |
| Profit Margin | -1% | -4% | -2% | 13% |
| Current Assets | 986 168 € | 1 427 931 € | 2 614 057 € | 3 851 711 € |
| Fixed Assets | 137 850 490 € | 142 722 555 € | 150 524 166 € | 177 330 335 € |
| Total Assets | 138 836 658 € | 144 150 486 € | 153 138 223 € | 181 182 046 € |
| Current Liabilities | 1 096 754 € | 2 687 757 € | 1 810 797 € | 10 104 656 € |
| Non Current Liabilities | 32 770 000 € | 36 735 000 € | 46 737 000 € | 65 565 857 € |
| Total Liabilities | 33 866 754 € | 39 422 757 € | 48 547 797 € | 75 670 513 € |
| Share Capital | 25 000 € | 25 000 € | 25 000 € | 25 000 € |
| Equity | 104 969 904 € | 104 727 729 € | 104 590 426 € | 105 511 533 € |
| Employees | 63 | 67 | 71 | 76 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 459 563.01 € | 469 709.41 € | 75 |
| 2023 Q4 | - | 797 194.51 € | 813 399.34 € | 77 |
| 2023 Q3 | - | 461 335.86 € | 477 901.87 € | 74 |
| 2023 Q2 | - | 405 269.14 € | 414 596.51 € | 71 |
| 2023 Q1 | - | 381 689.97 € | 397 292.13 € | 74 |
| 2022 Q4 | - | 460 717.23 € | 471 505.5 € | 69 |
| 2022 Q3 | - | 353 771.88 € | 371 647.96 € | 71 |
| 2022 Q2 | - | 317 993.52 € | 330 082.21 € | 74 |
| 2022 Q1 | - | 302 043.38 € | 313 615.29 € | 74 |
| 2021 Q4 | - | 398 339.79 € | 415 324.35 € | 70 |
| 2021 Q3 | - | 308 596.82 € | 324 244.07 € | 69 |
| 2021 Q2 | - | 285 653.78 € | 301 710.97 € | 66 |
| 2021 Q1 | - | 273 921.56 € | 286 871.06 € | 73 |
| 2020 Q4 | - | 366 509.27 € | 386 559.16 € | 71 |
| 2020 Q3 | - | 295 043.29 € | 312 219.18 € | 71 |
| 2020 Q2 | - | 321 029.75 € | 336 180.61 € | 68 |
| 2020 Q1 | - | 284 193.47 € | 293 202.33 € | 71 |
